WEBSITE BSE:532843 NSE: FORTIS Inc. Year: 1996 Industry: Hospital & Healthcare Services
Last updated: 15:52
Fortis Healthcare Ltd is an India-based incorporated healthcare shipping carrier provider. The Company is frequently engaged in the enterprise of healthcare services. It operates via 2 segments: Healthcare and Diagnostics. Its specialities comprises cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopaedics and ophthalmology, amongst others. It manages and operates a network of multi-area of expertise hospitals and diagnostics centres. The healthcare vertic...Read More
Fortis Healthcare Ltd is an India-based incorporated healthcare shipping carrier provider. The Company is frequently engaged in the enterprise of healthcare services. It operates via 2 segments: Healthcare and Diagnostics. Its specialities comprises cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopaedics and ophthalmology, amongst others. It manages and operates a network of multi-area of expertise hospitals and diagnostics centres. The healthcare verticals of the Company mainly includes hospitals, diagnostics and day care speciality centres. It has about 36 healthcare facilities, including tasks underneath development, 4000 operational beds and over 400 diagnostics centers. It operates in India, Sri Lanka, and United Arab Emirates.Its subsidiaries consist of Fortis Healthstaff Ltd, Escorts Heart Institute and Research Centre Ltd, Fortis Asia Healthcare Pte. Ltd, among others. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹67331 Cr.
Stock P/E 83.2
P/B 7.1
Current Price ₹891.9
Book Value ₹ 124.9
Face Value 10
52W High ₹1105
Dividend Yield 0.11%
52W Low ₹ 521.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1657 | 1770 | 1680 | 1786 | 1859 | 1988 | 1928 | 2007 | 2167 | 2331 |
| Other Income | 8 | 14 | 7 | 10 | 13 | 13 | 21 | 20 | 15 | 23 |
| Total Income | 1666 | 1783 | 1686 | 1796 | 1872 | 2002 | 1949 | 2027 | 2182 | 2354 |
| Total Expenditure | 1385 | 1440 | 1396 | 1405 | 1516 | 1554 | 1553 | 1572 | 1676 | 1775 |
| Operating Profit | 281 | 344 | 291 | 391 | 356 | 448 | 396 | 455 | 506 | 579 |
| Interest | 31 | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 |
| Depreciation | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 101 | 106 |
| Exceptional Income / Expenses | 1 | 4 | 8 | 3 | 0 | -60 | 24 | -54 | 13 | 24 |
| Profit Before Tax | 171 | 231 | 179 | 267 | 229 | 257 | 277 | 232 | 348 | 422 |
| Provision for Tax | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 | 84 | 97 |
| Profit After Tax | 125 | 183 | 130 | 199 | 173 | 189 | 252 | 183 | 264 | 325 |
| Adjustments | -13 | -9 | 5 | -20 | -7 | -12 | -4 | 1 | -4 | -3 |
| Profit After Adjustments | 112 | 174 | 135 | 179 | 166 | 176 | 248 | 184 | 260 | 322 |
| Adjusted Earnings Per Share | 1.5 | 2.3 | 1.8 | 2.4 | 2.2 | 2.3 | 3.3 | 2.4 | 3.4 | 4.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3966 | 4199 | 4574 | 4561 | 4469 | 4632 | 4030 | 5718 | 6298 | 6893 | 7783 | 8433 |
| Other Income | 96 | 153 | 166 | 140 | 92 | 53 | 47 | 27 | 62 | 38 | 67 | 79 |
| Total Income | 4062 | 4352 | 4740 | 4701 | 4562 | 4685 | 4077 | 5745 | 6359 | 6931 | 7850 | 8512 |
| Total Expenditure | 3835 | 3995 | 4221 | 4288 | 4244 | 4023 | 3626 | 4649 | 5196 | 5625 | 6195 | 6576 |
| Operating Profit | 226 | 358 | 519 | 413 | 318 | 662 | 451 | 1096 | 1163 | 1306 | 1655 | 1936 |
| Interest | 152 | 133 | 229 | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 258 |
| Depreciation | 235 | 225 | 222 | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 406 |
| Exceptional Income / Expenses | 0 | -40 | -2 | -881 | -222 | 62 | 1 | 315 | 74 | 16 | -89 | 7 |
| Profit Before Tax | -160 | 32 | 552 | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1007 | 1279 |
| Provision for Tax | 5 | -8 | 72 | 23 | 114 | 148 | 99 | 198 | 181 | 213 | 198 | 255 |
| Profit After Tax | -164 | 40 | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1024 |
| Adjustments | 20 | -21 | -58 | -75 | -75 | -34 | -54 | -235 | -44 | -46 | -35 | -10 |
| Profit After Adjustments | -144 | 18 | 422 | -1009 | -299 | 58 | -110 | 555 | 589 | 599 | 774 | 1014 |
| Adjusted Earnings Per Share | -3.1 | 0.4 | 8.1 | -19.5 | -4 | 0.8 | -1.5 | 7.4 | 7.8 | 7.9 | 10.3 | 13.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 11% | 11% | 7% |
| Operating Profit CAGR | 27% | 15% | 20% | 22% |
| PAT CAGR | 25% | 1% | 55% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 42% | 47% | 38% | 18% |
| ROE Average | 10% | 9% | 8% | 2% |
| ROCE Average | 12% | 12% | 11% | 6% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 4718 | 4461 | 5143 | 4062 | 6601 | 6661 | 6120 | 6178 | 7242 | 7663 | 8917 |
| Minority's Interest | 153 | 392 | 1167 | 1255 | 512 | 544 | 598 | 830 | 858 | 893 | 253 |
| Borrowings | 1004 | 867 | 1279 | 948 | 637 | 954 | 968 | 779 | 572 | 741 | 2086 |
| Other Non-Current Liabilities | 107 | -163 | -32 | -73 | 145 | 216 | 1866 | 2459 | 1991 | 504 | 515 |
| Total Current Liabilities | 1602 | 1450 | 1881 | 2133 | 3591 | 2578 | 1232 | 1268 | 1314 | 3170 | 1607 |
| Total Liabilities | 7585 | 7007 | 9484 | 8327 | 11486 | 10955 | 10784 | 11516 | 12089 | 12971 | 13377 |
| Fixed Assets | 4218 | 3642 | 5419 | 4992 | 8477 | 8802 | 8799 | 9416 | 9426 | 9874 | 10424 |
| Other Non-Current Assets | 1731 | 1951 | 2290 | 2053 | 1343 | 1212 | 949 | 967 | 1257 | 1677 | 1482 |
| Total Current Assets | 1636 | 1414 | 1728 | 1278 | 1666 | 938 | 1033 | 1130 | 1150 | 1420 | 1471 |
| Total Assets | 7585 | 7007 | 9484 | 8327 | 11486 | 10955 | 10784 | 11516 | 12089 | 12971 | 13377 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 249 | 179 | 123 | 348 | -165 | 634 | 7 | 219 | 67 | 45 | 170 |
| Cash Flow from Operating Activities | 24 | 195 | 966 | 493 | -179 | 172 | 485 | 865 | 822 | 1100 | 1424 |
| Cash Flow from Investing Activities | 213 | 113 | -1002 | -335 | -3323 | 60 | -135 | -514 | -374 | -886 | -779 |
| Cash Flow from Financing Activities | -304 | -354 | 259 | -672 | 4257 | -862 | -143 | -517 | -471 | -86 | -714 |
| Net Cash Inflow / Outflow | -67 | -47 | 224 | -515 | 755 | -630 | 207 | -166 | -23 | 127 | -69 |
| Closing Cash & Cash Equivalent | 183 | 142 | 348 | -165 | 634 | 7 | 219 | 67 | 45 | 170 | 100 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -3.11 | 0.4 | 8.14 | -19.46 | -3.96 | 0.77 | -1.45 | 7.35 | 7.8 | 7.93 | 10.26 |
| CEPS(Rs) | 1.52 | 5.72 | 13.55 | -13.41 | 0.12 | 5.08 | 3.11 | 14.45 | 12.57 | 13.08 | 15.83 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Book NAV/Share(Rs) | 87.46 | 89.67 | 99.01 | 77.77 | 87.12 | 88.18 | 81.04 | 81.81 | 95.91 | 101.48 | 118.08 |
| Core EBITDA Margin(%) | 3.29 | 4.86 | 7.72 | 5.99 | 5.04 | 13.16 | 10.04 | 18.7 | 17.49 | 18.39 | 20.4 |
| EBIT Margin(%) | -0.2 | 3.92 | 17.08 | -14.34 | 5.07 | 9.59 | 5.19 | 19.84 | 14.97 | 14.35 | 15.31 |
| Pre Tax Margin(%) | -4.02 | 0.75 | 12.06 | -19.99 | -2.46 | 5.17 | 1.07 | 17.28 | 12.92 | 12.45 | 12.94 |
| PAT Margin (%) | -4.14 | 0.95 | 10.48 | -20.49 | -5.01 | 1.98 | -1.39 | 13.82 | 10.05 | 9.36 | 10.4 |
| Cash Profit Margin (%) | 1.78 | 6.31 | 15.34 | -15.25 | 0.21 | 8.27 | 5.82 | 19.08 | 15.06 | 14.33 | 15.35 |
| ROA(%) | -2.13 | 0.54 | 5.81 | -10.49 | -2.26 | 0.82 | -0.52 | 7.08 | 5.36 | 5.15 | 6.14 |
| ROE(%) | -3.94 | 0.97 | 10.33 | -20.4 | -4.22 | 1.38 | -0.88 | 12.85 | 9.44 | 8.66 | 9.77 |
| ROCE(%) | -0.12 | 2.64 | 11.72 | -9.77 | 3.11 | 5.36 | 2.72 | 15.61 | 12.5 | 12.01 | 12.14 |
| Receivable days | 39.12 | 37.09 | 36.59 | 37.74 | 41.35 | 39.44 | 41.5 | 30.96 | 31.7 | 32.02 | 33.12 |
| Inventory Days | 5.8 | 5.39 | 4.85 | 5.13 | 5.03 | 5.31 | 7.02 | 6.37 | 7.12 | 6.1 | 5.22 |
| Payable days | 197.33 | 211.28 | 210.4 | 246.88 | 298.12 | 255.83 | 214.28 | 162.58 | 172.53 | 162.59 | 153.11 |
| PER(x) | 0 | 441.05 | 22.11 | 0 | 0 | 164.26 | 0 | 39.49 | 33.33 | 52.93 | 68.11 |
| Price/Book(x) | 1.88 | 1.96 | 1.82 | 1.59 | 1.56 | 1.43 | 2.46 | 3.55 | 2.71 | 4.14 | 5.92 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.38 | 0.24 | 0.14 |
| EV/Net Sales(x) | 2.49 | 2.33 | 2.4 | 1.79 | 2.54 | 2.29 | 3.94 | 3.93 | 3.17 | 4.64 | 6.99 |
| EV/Core EBITDA(x) | 43.63 | 27.33 | 21.19 | 19.72 | 35.79 | 16.01 | 35.21 | 20.5 | 17.17 | 24.47 | 32.89 |
| Net Sales Growth(%) | 13.57 | 5.88 | 8.93 | -0.28 | -2.01 | 3.65 | -13 | 41.87 | 10.14 | 9.45 | 12.91 |
| EBIT Growth(%) | -124.62 | 2222.8 | 374.13 | -183.72 | 134.67 | 96.01 | -52.93 | 442.43 | -16.91 | 4.89 | 20.48 |
| PAT Growth(%) | 28.45 | 124.21 | 1106.81 | -294.96 | 76.06 | 140.9 | -161.39 | 1506.38 | -19.87 | 1.93 | 25.44 |
| EPS Growth(%) | -217.26 | 112.81 | 1947.39 | -338.91 | 79.65 | 119.38 | -289.46 | 605.74 | 6.05 | 1.72 | 29.28 |
| Debt/Equity(x) | 0.38 | 0.34 | 0.43 | 0.49 | 0.3 | 0.2 | 0.21 | 0.16 | 0.1 | 0.11 | 0.25 |
| Current Ratio(x) | 1.02 | 0.97 | 0.92 | 0.6 | 0.46 | 0.36 | 0.84 | 0.89 | 0.88 | 0.45 | 0.92 |
| Quick Ratio(x) | 0.99 | 0.93 | 0.89 | 0.57 | 0.45 | 0.33 | 0.78 | 0.79 | 0.78 | 0.41 | 0.84 |
| Interest Cover(x) | -0.05 | 1.24 | 3.4 | -2.54 | 0.67 | 2.17 | 1.26 | 7.73 | 7.3 | 7.55 | 6.46 |
| Total Debt/Mcap(x) | 0.23 | 0.19 | 0.24 | 0.31 | 0.19 | 0.14 | 0.08 | 0.04 | 0.04 | 0.03 | 0.04 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 |
| FII | 30.03 | 23.71 | 23.24 | 23.31 | 25.26 | 26.77 | 27.4 | 27.17 | 27.9 | 27.84 |
| DII | 22.16 | 29.41 | 31.15 | 32.31 | 30.73 | 30.05 | 29.46 | 29.79 | 29.14 | 29.33 |
| Public | 16.64 | 15.71 | 14.45 | 13.22 | 12.84 | 12.01 | 11.97 | 11.87 | 11.79 | 11.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 | 23.53 |
| FII | 22.67 | 17.9 | 17.54 | 17.6 | 19.07 | 20.21 | 20.69 | 20.52 | 21.07 | 21.02 |
| DII | 16.73 | 22.2 | 23.52 | 24.39 | 23.2 | 22.69 | 22.24 | 22.49 | 22 | 22.14 |
| Public | 12.57 | 11.86 | 10.91 | 9.98 | 9.69 | 9.07 | 9.04 | 8.96 | 8.9 | 8.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 | 75.5 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
